Plant polysaccharides influence tumor development based on epigenetics: a review
- PMID: 40395727
- PMCID: PMC12089089
- DOI: 10.3389/fphar.2025.1588857
Plant polysaccharides influence tumor development based on epigenetics: a review
Abstract
Plant polysaccharides have emerged as pivotal epigenetic modulators in oncology, offering multi-target therapeutic potential to address toxicity and drug resistance limitations of conventional therapies. This review integrates evidences from multi-database (PubMed, Web of Science and CNKI, 2010-2025) to elucidate three core epigenetic mechanisms of plant polysaccharides (e.g., Astragalus and Ganoderma lucidum): 1) TET2-mediated DNA demethylation; 2) inhibition of histone-modifying enzymes including JMJD2D; 3) regulation of tumor-suppressive miRNAs such as miR-139-5p. Preclinical studies demonstrate synergistic effects with chemotherapeutics, enhancing antitumor efficacy while reducing toxicity through immune modulation (e.g., H22 murine models) and organ protection (e.g., cisplatin regimens). Bibliometric analyses further uncover emerging roles in tumor microenvironment reprogramming, angiogenesis suppression, and macrophage polarization. These findings establish plant polysaccharides as precision oncology agents bridging molecular mechanisms with clinical translation. Future research should prioritize structural standardization, pharmacokinetic profiling, and combinatorial therapy optimization to accelerate clinical translation.
Keywords: apoptosis; epigenetic; oncology agent; plant polysaccharides; tumor development.
Copyright © 2025 Li, Hu and Yang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment.Discov Oncol. 2023 Sep 24;14(1):179. doi: 10.1007/s12672-023-00798-w. Discov Oncol. 2023. PMID: 37741920 Free PMC article. Review.
-
Structure Identification of Ganoderma lucidum Spore Polysaccharides and Their Antitumor Activity In Vivo.Molecules. 2024 May 16;29(10):2348. doi: 10.3390/molecules29102348. Molecules. 2024. PMID: 38792209 Free PMC article.
-
The Pharmacological Rationales and Molecular Mechanisms of Ganoderma lucidum Polysaccharides for the Therapeutic Applications of Multiple Diseases.Am J Chin Med. 2022;50(1):53-90. doi: 10.1142/S0192415X22500033. Epub 2021 Dec 28. Am J Chin Med. 2022. PMID: 34963429 Review.
-
Astragalus polysaccharides (PG2) Enhances the M1 Polarization of Macrophages, Functional Maturation of Dendritic Cells, and T Cell-Mediated Anticancer Immune Responses in Patients with Lung Cancer.Nutrients. 2019 Sep 20;11(10):2264. doi: 10.3390/nu11102264. Nutrients. 2019. PMID: 31547048 Free PMC article.
-
Macrophage Polarisation in the Tumour Microenvironment: Recent Research Advances and Therapeutic Potential of Different Macrophage Reprogramming.Cancer Control. 2025 Jan-Dec;32:10732748251316604. doi: 10.1177/10732748251316604. Cancer Control. 2025. PMID: 39849988 Free PMC article. Review.
Cited by
-
From laboratory to clinic: opportunities and challenges of functional food active ingredients in cancer therapy.Front Nutr. 2025 Jul 30;12:1627949. doi: 10.3389/fnut.2025.1627949. eCollection 2025. Front Nutr. 2025. PMID: 40808836 Free PMC article. Review.
References
-
- Abu-Khudir R., Ismail G. A., Diab T. (2020). Antimicrobial, antioxidant, and anti-tumor activities of sargassum linearifolium and cystoseira crinita from egyptian mediterranean coast. Nutr. Cancer (1), 1–16. - PubMed
-
- Ahmad M. M., Chatha S. a.S., Iqbal Y., Hussain A. I., Khan I., Xie F. W. (2022). Recent trends in extraction, purification, and antioxidant activity evaluation of plant leaf-extract polysaccharides. Biofuels Bioprod. and Biorefining-Biofpr 16 (6), 1820–1848. 10.1002/bbb.2405 - DOI
Publication types
LinkOut - more resources
Full Text Sources